Domain-informed effector gene assignment exposes training-data dependence of drug target prioritisation from GWAS

About 90% of trait-associated lead variants lie outside protein-coding regions, so nominating the effector gene at genome-wide association study (GWAS) loci remains the principal bottleneck in translating associations into biological insight. Since no experimentally resolved ground truth exists at scale, every method rests on quasi-true-positive sets dominated by a single line of evidence. Here, we benchmarked established prioritisation methods across three independent evaluation sets, trained five models each informed by a different biological domain, and annotated lead variants for six common diseases. Performance did not transfer across domains (AUPRC 0.91 to 0.46 for the same method), and we traced this to how differently models weight the distance between variant and gene (p<5.3x10 -123 ), not to how they were built. Curation assumptions propagated into predictions and can become self-confirming, such as druggability in the Open Targets-informed model. The five models shared only 17.1% to 31.8% of effector gene assignments, converging on established disease biology but diverging where GWAS are expected to yield novel insight. Recovery of 340 approved drug targets differed markedly between models, and no way of combining them, by averaging scores (38.8%) or training on all curations jointly (36.5%), approached the 52.1% recovered across all five together. Our workflow matched Open Targets L2G across three annotation sets without prior biological knowledge and exceeded it where curated knowledge already linked gene and disease. We provide the Domain-informed EFfector gene Assignment framework (DEFA; https://github.com/lkohleick/DEFA), which reports rather than hides the curation assumption behind each gene assignment so that it can be examined and tested.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.17.766419
Primary Topic
Genetic Associations and Epidemiology
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Domain-informed effector gene assignment exposes training-data dependence of drug target prioritisation from GWAS

Maik Pietzner, Martijn Zoodsma, Carl Friedrich Beuchel, Benjamin Wild et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Genetic Associations and Epidemiology
preprint

Domain-informed effector gene assignment exposes training-data dependence of drug target prioritisation from GWAS

Maik Pietzner, Martijn Zoodsma, Carl Friedrich Beuchel, Benjamin Wild, Kurt Herzog, Claudia Langenberg, Leonhard Kohleick
preprint en

Abstract

About 90% of trait-associated lead variants lie outside protein-coding regions, so nominating the effector gene at genome-wide association study (GWAS) loci remains the principal bottleneck in translating associations into biological insight. Since no experimentally resolved ground truth exists at scale, every method rests on quasi-true-positive sets dominated by a single line of evidence. Here, we benchmarked established prioritisation methods across three independent evaluation sets, trained five models each informed by a different biological domain, and annotated lead variants for six common diseases. Performance did not transfer across domains (AUPRC 0.91 to 0.46 for the same method), and we traced this to how differently models weight the distance between variant and gene (p<5.3x10 -123 ), not to how they were built. Curation assumptions propagated into predictions and can become self-confirming, such as druggability in the Open Targets-informed model. The five models shared only 17.1% to 31.8% of effector gene assignments, converging on established disease biology but diverging where GWAS are expected to yield novel insight. Recovery of 340 approved drug targets differed markedly between models, and no way of combining them, by averaging scores (38.8%) or training on all curations jointly (36.5%), approached the 52.1% recovered across all five together. Our workflow matched Open Targets L2G across three annotation sets without prior biological knowledge and exceeded it where curated knowledge already linked gene and disease. We provide the Domain-informed EFfector gene Assignment framework (DEFA; https://github.com/lkohleick/DEFA), which reports rather than hides the curation assumption behind each gene assignment so that it can be examined and tested.

bioRxiv (Cold Spring Harbor Laboratory)
Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
Good health and well-being
Genetic Associations and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon